Dharma Productions, the banner behind Bollywood tentpoles like the "Kuch Kuch Hota Hai" and "Kabhi Khushi Kabhie Gham" franchises, is pivoting toward historical prestige cinema with an ambitious biopic on Rameshwar Nath Kao, the founding chief of India's Research and Analysis Wing. The production company, helmed by filmmaker Karan Johar, confirmed the project in partnership with Leo Media Collective, a move that signals Dharma's evolution beyond romantic dramas and into the biographical thriller space that has gained traction across Indian cinema.
The film targets an August 11, 2028 theatrical release, deliberately positioned for India's Independence Day weekend. The timing reflects industry strategy in Bollywood, where patriotic narratives and historical dramas anchored to national holidays command strong audience turnout and box office momentum. This release window places the Kao biopic in competition with other prestige releases but also capitalizes on the cultural calendar that drives Indian film distribution.
Rameshwar Nath Kao founded India's RAW in 1968, consolidating the nation's foreign intelligence operations during a pivotal Cold War era. Kao served as the agency's first chief for over a decade, shaping India's intelligence apparatus during crucial geopolitical moments. His legacy extends beyond institutional founding into operational history that remains partially classified, offering filmmakers both narrative intrigue and the real constraints of dramatizing classified material.
This project represents a shift in Dharma Productions' portfolio. The company built its empire on romantic comedies and family dramas aimed at diaspora audiences and domestic multiplexes. Recent years saw Johar branch into action franchises with films like "Jawan" (through production partnership) and darker thrillers, but a straight historical biopic about an espionage figure marks new territory. The partnership with Leo Media Collective, known for producing content with international sensibilities, suggests Dharma intends this as a crossover play, potentially targeting global festival circuits and international streaming platforms alongside theatrical release in India.
The spy thriller remains a reliably commercial genre in India. Films like "RawFilms" and franchises centered on intelligence work have performed well both domestically and on OTT platforms. An authorized biopic benefits from institutional credibility, though it may face editorial constraints around portraying classified operations. The challenge for writers and director will be balancing historical authenticity with dramatic momentum, particularly given the geopolitical sensitivities surrounding RAW operations during the Cold War period.
No director or lead actor has been announced. The 2028 timeline suggests pre-production is underway, with casting likely to follow once the script reaches advanced stages. For Dharma, this project positions the banner as willing to tackle India's modern history with the same commercial acumen it applied to romance. For Indian cinema more broadly, it reflects growing appetite for intelligent historical dramas that blend prestige storytelling with box office ambitions, especially when anchored to national occasions that guarantee audience engagement.